Akanda Corp Acquires Holigen Limited
May 2, 2022
Akanda Corp entered into a definitive agreement to acquire 100% of Holigen Limited from The Flowr Corporation, adding cultivation, EU GMP manufacturing, and distribution capacity in Portugal. The deal was later reported as closed, positioning Akanda to accelerate its seed-to-patient model across EMEA and to scale toward adult-use opportunities as regulations evolve.
- Buyers
- Akanda Corp.
- Targets
- Holigen Limited, RPK Biopharma Unipessoal, Lda
- Sellers
- The Flowr Corporation
- Industry
- Healthcare Services
- Location
- Portugal
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Hempsana Holdings Ltd. Completes Acquisition of Hempsana Inc.
July 12, 2021
Pharmaceuticals
Hempsana Holdings Ltd. (formerly Stralak Resource Inc.) completed a previously announced three‑cornered amalgamation to acquire Hempsana Inc., making Hempsana a wholly‑owned subsidiary. The combined company will focus on manufacturing cannabis derivatives and extracts (including vapeables, topicals and infused consumables) from Hempsana's Health Canada standard processing licensed and EU‑GMP‑compliant facility; HHL's shares are expected to trade on the Canadian Securities Exchange under the ticker HMPS.
-
GrowerIQ Acquires Ample Organics from Akerna
January 15, 2024
Software
Toronto-based GrowerIQ has acquired fellow cannabis software provider Ample Organics from U.S.-based Akerna in an all-cash deal that closed in December; financial terms were not disclosed. The acquisition brings Ample's seven employees onto GrowerIQ's ~25-person team and combines two seed-to-sale ERP platforms to create what GrowerIQ calls the largest cannabis tech platform in Canada (and a stronger position in Europe).
-
PharmaForceIQ Acquires Aktana
January 9, 2026
Cloud & SaaS
PharmaForceIQ has acquired Aktana in an asset acquisition to integrate Aktana's AI-driven field Next-Best-Action platform into PharmaForceIQ's digital orchestration offering. The deal is intended to create an end-to-end 'optichannel-in-a-box' commercial engagement solution for life sciences, deepen PharmaForceIQ's U.S. footprint and expand reach across LATAM, APAC and EMEA; Canaccord Genuity acted as sole financial advisor.
-
GenCanna Acquires CBD Capital Ltd
September 1, 2021
Manufacturing
GenCanna, a Kentucky-based vertically integrated CBD manufacturer, has acquired London-based CBD Capital Ltd to expand its bulk ingredient and finished-goods operations across the United Kingdom, the European Union and other global markets. The deal broadens GenCanna’s formulation and distribution capabilities in Europe; CBD Capital CEO Hassan Akhtar will remain in his role.
-
Curaleaf Holdings Acquires Northern Green Canada
March 19, 2024
Pharmaceuticals
Curaleaf Holdings, Inc. has signed a deal to acquire Northern Green Canada, an EU-GMP certified Canadian licensed cannabis producer, to secure high-quality indoor EU-GMP flower supply and bolster Curaleaf's European and Australasian expansion. The acquisition is expected to close in Q2 2024 pending regulatory approvals and will strengthen Curaleaf's supply chain for key markets including Germany, Australia/New Zealand and the U.K.
-
HempFusion Acquires Apothecanna
May 17, 2021
Consumer Products
HempFusion Wellness Inc. has acquired 100% of APCNA Holdings LLC (Apothecanna) for initial consideration of US$15.0 million, with up to US$10.0 million in additional milestone payments tied to revenue targets. The deal expands HempFusion's retail distribution (adding ~1,800 stores including CVS), bolsters its e-commerce presence, and is immediately accretive based on Apothecanna's ~US$3.8–4.0 million 2020 revenue.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.